Standard opioid agonists activate heteromeric opioid receptors: Evidence for morphine and [ d -Ala2-MePhe4-Glyol 5]enkephalin as selective μ-delta; Agonists

ACS Chemical Neuroscience

Volumn 1, Issue 2, 2010, Pages 146-154

  Yekkirala, Ajay S ^a   Kalyuzhny, Alexander E ^a   Portoghese, Philip S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Heterodimers; Heteromers; Morphine; Opioid; Receptors; Standard opioids

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; BREMAZOCINE; DELTA OPIATE RECEPTOR AGONIST; DELTORPHIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; MORPHINE; MU OPIATE RECEPTOR AGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; OPIATE AGONIST; OPIATE RECEPTOR;

ANTINOCICEPTION; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL;

HETERODIMERS; HETEROMERS; MORPHINE; OPIOID; RECEPTORS; STANDARD OPIOIDS;

ANALGESICS, OPIOID; AREA UNDER CURVE; BENZENEACETAMIDES; CALCIUM SIGNALING; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HEK293 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LIGANDS; MORPHINE; PYRROLIDINES; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU;

EID: 77952949502     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn9000236     Document Type: Article

References (59)

1. Evans, C. J., Keith, D. E., Jr., Morrison, H., Magendzo, K. and Edwards, R. H. (1992) Cloning of a delta opioid receptor by functional expression Science 258, 1952-1955
2. Kieffer, B. L., Befort, K., Gaveriaux-Ruff, C. and Hirth, C. G. (1992) The delta-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization Proc. Natl. Acad. Sci. U.S.A. 89, 12048-12052
3. Meng, F., Xie, G. X., Thompson, R. C., Mansour, A., Goldstein, A., Watson, S. J. and Akil, H. (1993) Cloning and pharmacological characterization of a rat kappa opioid receptor Proc. Natl. Acad. Sci. U.S.A. 90, 9954-9958 (Pubitemid 23328229)
4. Thompson, R. C., Mansour, A., Akil, H. and Watson, S. J. (1993) Cloning and pharmacological characterization of a rat mu opioid receptor Neuron 11, 903-913 (Pubitemid 23347475)
5. Portoghese, P. S. (1965) A new concept on the mode of interaction of narcotic analgesics with receptors J. Med. Chem. 8, 609-616
6. Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E. and Gilbert, P. E. (1976) The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog J. Pharmacol. Exp. Ther. 197, 517-532
7. Lord, J. A., Waterfield, A. A., Hughes, J. and Kosterlitz, H. W. (1977) Endogenous opioid peptides: Multiple agonists and receptors Nature 267, 495-499
8. Su, T. P., Clements, T. H. and Gorodetzky, C. W. (1981) Multiple opiate receptors in guinea-pig ileum Life Sci. 28, 2519-2528
9. Tyers, M. B. (1980) A classification of opiate receptors that mediate antinociception in animals Br. J. Pharmacol. 69, 503-512
10. Handa, B. K., Land, A. C., Lord, J. A., Morgan, B. A., Rance, M. J. and Smith, C. F. (1981) Analogues of beta-LPH61-64 possessing selective agonist activity at mu-opiate receptors Eur. J. Pharmacol. 70, 531-540
11. Zhao, G. M., Qian, X., Schiller, P. W. and Szeto, H. H. (2003) Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors J. Pharmacol. Exp. Ther. 307, 947-954
12. Mosberg, H. I., Hurst, R., Hruby, V. J., Gee, K., Yamamura, H. I., Galligan, J. J. and Burks, T. F. (1983) Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors Proc. Natl. Acad. Sci. U.S.A. 80, 5871-5874
13. Qi, J. A., Mosberg, H. I. and Porreca, F. (1990) Antinociceptive effects of [D-Ala2]deltorphin II, a highly selective delta agonist in vivo Life Sci. 47, PL43-47
14. Kreil, G., Barra, D., Simmaco, M., Erspamer, V., Erspamer, G. F., Negri, L., Severini, C., Corsi, R. and Melchiorri, P. (1989) Deltorphin, a novel amphibian skin peptide with high selectivity and affinity for delta opioid receptors Eur. J. Pharmacol. 162, 123-128
15. Lahti, R. A., Mickelson, M. M., McCall, J. M. and Von Voigtlander, P. F. (1985) 3H]U-69593 a highly selective ligand for the opioid kappa receptor Eur. J. Pharmacol. 109, 281-284
16. Leighton, G. E., Rodriguez, R. E., Hill, R. G. and Hughes, J. (1988) kappa-Opioid agonists produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat Br. J. Pharmacol. 93, 553-560
17. Prinster, S. C., Hague, C. and Hall, R. A. (2005) Heterodimerization of G protein-coupled receptors: Specificity and functional significance Pharmacol. Rev. 57, 289-298
18. Milligan, G. (2009) G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function. Br. J. Pharmacol. DOI: BPH169 [pii]10.1111/j.1476-5381.2009.00169.x
19. Jordan, B. A. and Devi, L. A. (1999) G-protein-coupled receptor heterodimerization modulates receptor function Nature 399, 697-700
20. George, S. R., Fan, T., Xie, Z., Tse, R., Tam, V., Varghese, G. and O'Dowd, B. F. (2000) Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties J. Biol. Chem. 275, 26128-26135
21. Gomes, I., Jordan, B. A., Gupta, A., Trapaidze, N., Nagy, V. and Devi, L. A. (2000) Heterodimerization of mu and delta opioid receptors: A role in opiate synergy J. Neurosci. 20, RC110
22. Pfeiffer, M., Koch, T., Schroder, H., Laugsch, M., Hollt, V. and Schulz, S. (2002) Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization J. Biol. Chem. 277, 19762-19772
23. Jordan, B. A., Gomes, I., Rios, C., Filipovska, J. and Devi, L. A. (2003) Functional interactions between mu opioid and alpha 2A-adrenergic receptors Mol. Pharmacol. 64, 1317-1324
24. Chen, C., Li, J., Bot, G., Szabo, I., Rogers, T. J. and Liu-Chen, L.-Y. (2004) Heterodimerization and cross-desensitization between the μ-opioid receptor and the chemokine CCR5 receptor Eur. J. Pharmacol. 483, 175-186
25. Zhang, Y. Q. and Limbird, L. E. (2004) Hetero-oligomers of alpha2A-adrenergic and mu-opioid receptors do not lead to transactivation of G-proteins or altered endocytosis profiles Biochem. Soc. Trans. 32, 856-860
26. Rios, C., Gomes, I. and Devi, L. A. (2004) Interactions between delta opioid receptors and alpha-adrenoceptors Clin. Exp. Pharmacol. Physiol. 31, 833-836
27. Wang, D., Sun, X., Bohn, L. M. and Sadee, W. (2005) Opioid receptor homo- and heterodimerization in living cells by quantitative bioluminescence resonance energy transfer Mol. Pharmacol. 67, 2173-2184
28. Wang, H.-L., Hsu, C.-Y., Huang, P.-C., Kuo, Y.-L., Li, A. H., Yeh, T.-H., Tso, A.-S. and Chen, Y.-L. (2005) Heterodimerization of opioid receptor-like 1 and μ-opioid receptors impairs the potency of μ receptor agonist J. Neurochem. 92, 1285-1294
29. Mackie, K. (2005) Cannabinoid receptor homo- and heterodimerization Life Sci. 77, 1667-1673
30. Terrillon, S., Durroux, T., Mouillac, B., Breit, A., Ayoub, M. A., Taulan, M., Jockers, R., Barberis, C. and Bouvier, M. (2003) Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis Mol. Endocrinol. 17, 677-691
31. Salahpour, A., Angers, S., Mercier, J. F., Lagace, M., Marullo, S. and Bouvier, M. (2004) Homodimerization of the beta2-adrenergic receptor as a prerequisite for cell surface targeting J. Biol. Chem. 279, 33390-33397
32. Hasbi, A., Nguyen, T., Fan, T., Cheng, R., Rashid, A., Alijaniaram, M., Rasenick, M. M., O'Dowd, B. F. and George, S. R. (2007) Trafficking of preassembled opioid mu-delta heterooligomer-Gz signaling complexes to the plasma membrane: Coregulation by agonists Biochemistry 46, 12997-13009
33. Bhushan, R. G., Sharma, S. K., Xie, Z., Daniels, D. J. and Portoghese, P. S. (2004) A bivalent ligand (KDN-21) reveals spinal delta and kappa opioid receptors are organized as heterodimers that give rise to delta(1) and kappa(2) phenotypes. Selective targeting of delta -k heterodimers J. Med. Chem. 47, 2969-2972
34. Waldhoer, M., Fong, J., Jones, R. M., Lunzer, M. M., Sharma, S. K., Kostenis, E., Portoghese, P. S. and Whistler, J. L. (2005) A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers Proc. Natl. Acad. Sci. U.S.A. 102, 9050-9055
35. Daniels, D. J., Lenard, N. R., Etienne, C. L., Law, P. Y., Roerig, S. C. and Portoghese, P. S. (2005) Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series Proc. Natl. Acad. Sci. U.S.A. 102, 19208-19213
36. Yekkirala, A. and Portoghese, P. S. (2008) Identification of clinically employed analgesics whose pharmacology is mediated through putative heterodimeric opioid receptors, Presented at the 70th annual meeting, College on Problems of Drug Dependence, Puerto Rico, USA.
37. Romer, D., Buscher, H., Hill, R. C., Maurer, R., Petcher, T. J., Welle, H. B., Bakel, H. C. and Akkerman, A. M. (1980) Bremazocine: A potent, long-acting opiate kappa-agonist Life Sci. 27, 971-978
38. van Rijn, R. M. and Whistler, J. L. (2009) The δ1 opioid receptor is a heterodimer that opposes the actions of the δ2 receptor on alcohol intake Biol. Psychiatry 66, 777-784
39. Kostenis, E. (2001) Is Galpha16 the optimal tool for fishing ligands of orphan G-protein-coupled receptors? Trends Pharmacol. Sci. 22, 560-564
40. Abdelhamid, E. E., Sultana, M., Portoghese, P. S. and Takemori, A. E. (1991) Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice J. Pharmacol. Exp. Ther. 258, 299-303
41. Zhu, Y., King, M. A., Schuller, A. G., Nitsche, J. F., Reidl, M., Elde, R. P., Unterwald, E., Pasternak, G. W. and Pintar, J. E. (1999) Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice Neuron 24, 243-252
42. Kest, B., Lee, C. E., McLemore, G. L. and Inturrisi, C. E. (1996) An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice Brain Res. Bull. 39, 185-188
43. Sanchez-Blazquez, P., Garcia-Espana, A. and Garzon, J. (1997) Antisense oligodeoxynucleotides to opioid mu and delta receptors reduced morphine dependence in mice: role of delta-2 opioid receptors J. Pharmacol. Exp. Ther. 280, 1423-1431
44. Lenard, N. R., Daniels, D. J., Portoghese, P. S. and Roerig, S. C. (2007) Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores Br. J. Pharmacol. 566, 75-82
45. Rothman, R. B. and Xu, H. (2004) Mu-delta interactions in vitro and in vivo., in The Delta Receptor (Chang, K., Porreca, F. and Woods, J. H., Eds.) 1 st ed., pp 373 - 382, Marcel Dekker, Inc., New York.
46. Devine, D. P. and Wise, R. A. (1994) Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats J. Neurosci. 14, 1978-1984
47. Aley, K. O., Green, P. G. and Levine, J. D. (1995) Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal J. Neurosci. 15, 8031-8038
48. Meyer, P. J., Fossum, E. N., Ingram, S. L. and Morgan, M. M. (2007) Analgesic tolerance to microinjection of the micro-opioid agonist DAMGO into the ventrolateral periaqueductal gray Neuropharmacology 52, 1580-1585
49. Horan, P., de Costa, B. R., Rice, K. C. and Porreca, F. (1991) Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice J. Pharmacol. Exp. Ther. 257, 1154-1161
50. Caudle, R. M., Finegold, A. A., Mannes, A. J., Tobias, M. D., Kenshalo, D. R., Jr. and Iadarola, M. J. (1998) Spinal kappa1 and kappa2 opioid binding sites in rats, guinea pigs, monkeys and humans Neuroreport 9, 2523-2525
51. Lunzer, M. M. and Portoghese, P. S. (2007) Selectivity of delta- and kappa-opioid ligands depends on the route of central administration in mice J. Pharmacol. Exp. Ther. 322, 166-171
52. Navarro, H. A. (2008) Functional characterization of bremazocine isomers at human opioid receptors using calcium mobilization., Presented at the 39th annual meeting, International Narcotics Research Conference, Charleston, SC.
53. Simonin, F., Slowe, S., Becker, J. A., Matthes, H. W., Filliol, D., Chluba, J., Kitchen, I. and Kieffer, B. L. (2001) Analysis of [3H]bremazocine binding in single and combinatorial opioid receptor knockout mice Eur. J. Pharmacol. 414, 189-195
54. Sofuoglu, M., Portoghese, P. S. and Takemori, A. E. (1993) 7-Benzylidenenaltrexone (BNTX): a selective delta 1 opioid receptor antagonist in the mouse spinal cord Life Sci. 52, 769-775
55. Sofuoglu, M., Portoghese, P. S. and Takemori, A. E. (1991) Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: Evidence for delta opioid receptor subtypes J. Pharmacol. Exp. Ther. 257, 676-680
56. Jiang, Q., Takemori, A. E., Sultana, M., Portoghese, P. S., Bowen, W. D., Mosberg, H. I. and Porreca, F. (1991) Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: Evidence for delta receptor subtypes J. Pharmacol. Exp. Ther. 257, 1069-1075
57. Portoghese, P. S. and Lunzer, M. M. (2003) Identity of the putative delta1-opioid receptor as a delta-kappa heteromer in the mouse spinal cord Eur. J. Pharmacol. 467, 233-234
58. Simon, E. J. and Gioannini, T. L. (1993) Opioid receptor multiplicity: Isolation, purification, and chemical characterization of binding sites., in Opioids-I (Herz, A., Ed.) 1 st ed., pp 3 - 26, Springer-Verlag, Berlin Heidelberg.
59. Mullaney, I. (1999) G proteins and their identification, in Signal Transduction: A practical approach. (Milligan, G., Ed.) 2 nd ed., pp 100 - 101, Oxford University Press, Oxford, U.K.